Top 20 would not have changed too much, with only five million sold or transferred the last month or two, its not going to make a big difference
Management know this companies potential worth, it’s not 500 million or 2 billion. Orthocell needs to prove these products are the best over two or three years when partnered up. A duel listing will be written into the contract after a time frame has lapsed and products are a clear winner.
Why would they buy out an Aussie company, when in 2, 3, 5 years time for a few billion, when they will own part of the duel listing, worth US 20-30 billion and keep the money in the good old mighty US of A
It’s just smart business, profitable business
Top 20 would not have changed too much, with only five million...
-
- There are more pages in this discussion • 1,274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $65.26K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56760 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.04pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |